DaVita HealthCare Partners(DVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DVA DaVita HealthCare Partners

Market Closed 08-28 16:00:00 EDT

180.68

+1.80

+1.01%

盘后180.68

+0.000.00%

19:44 EDT

High182.53	Low178.80	Vol461.80K
Open180.00	D1 Closing178.88	Amplitude2.09%
Mkt Cap11.60B	Tradable Cap5.90B	Total Shares64.20M
T/O83.60M	T/O Rate1.42%	Tradable Shares32.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DVA","market":"US","secType":"STK","nameCN":"DaVita HealthCare Partners","latestPrice":180.68,"timestamp":1787947200000,"preClose":178.88,"halted":0,"volume":461800,"hourTrading":{"tag":"盘后","latestPrice":180.68,"preClose":180.68,"latestTime":"19:44 EDT","volume":19756,"amount":3569540.2135,"timestamp":1787960697732,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.010062611806797917,"floatShares":32629699,"shares":64200000,"eps":12.13,"marketStatus":"Market Closed","change":1.8,"latestTime":"08-28 16:00:00 EDT","open":180,"high":182.53,"low":178.8004,"amount":83595488.56400001,"amplitude":0.02085,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":12.13,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":815029200000,"exchange":"NYSE","adjPreClose":178.88,"preHourTrading":{"tag":"盘前","latestPrice":179.51,"preClose":178.88,"latestTime":"09:29 EDT","volume":89,"amount":15987.78912,"timestamp":1787923757566,"change":0.63,"changeRate":0.003522,"amplitude":0.006261},"postHourTrading":{"tag":"盘后","latestPrice":180.68,"preClose":180.68,"latestTime":"19:44 EDT","volume":19756,"amount":3569540.2135,"timestamp":1787960697732,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.691349,"impliedVol":0.3023,"impliedVolPercentile":0.1235},"requestUrl":"/m/hq/s/DVA/tweets","defaultTab":"tweets","newsList":[{"id":"2663154420","title":"DaVita Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2663154420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663154420?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:14","pubTimestamp":1787951640,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  rose 1.01% to $180.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.DaVita Inc. closed 27.00% below its 52-week high of $247.49, which the company achieved on August 3rd.The stock outperformed some of its competitors Friday, as UnitedHealth Group Inc.  fell 0.53% to $392.95, Icon PLC  rose 0.18% to $170.02, and Quest Diagnostics Inc.  fell 0.76% to $242.76.Trading volume  remained 407,837 below its 50-day average volume of 869,547.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DVA","BK4559","BK4588","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273771","title":"Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273771","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:22","pubTimestamp":1787808154,"startTime":"0","endTime":"0","summary":"DaVita Inc. recently announced it has entered into a value-based care agreement with Humana Inc. to provide coordinated care for more than 10,000 Medicare Advantage members with chronic kidney disease stages 3B–5, building on their long-standing collaboration in end stage kidney disease.\nThe partnership, delivered through DaVita Integrated Kidney Care and an extensive network of 3,000 value-based nephrologist partners, is designed to engage patients earlier in their disease journey with...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-dva/davita/news/will-davitas-dva-expanded-humana-ckd-partnership-reshape-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-dva/davita/news/will-davitas-dva-expanded-humana-ckd-partnership-reshape-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU1983260115.SGD","SG9999014005.SGD","LU0320765489.SGD","LU0390134368.USD","LU0070302665.USD","HUM","LU0170899867.USD","LU0238689110.USD","SG9999014013.SGD","BK4196","BK4588","BK4566","SG9999014021.USD","BK4559","DVA","LU0348723411.USD","LU0256863811.USD","LU0208291251.USD","LU0417517546.SGD","LU0211331839.USD","BK4533","LU1093756325.SGD","BK4154","FXH","LU0266013472.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662478717","title":"DaVita Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662478717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662478717?lang=en_us&edition=fundamental","pubTime":"2026-08-27 05:16","pubTimestamp":1787778960,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  rallied 1.27% to $180.05 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88.This was the stock's third consecutive day of gains.DaVita Inc. closed 27.25% below its 52-week high of $247.49, which the company reached on August 3rd.The stock outperformed some of its competitors Wednesday, as UnitedHealth Group Inc.  rose 1.11% to $401.01, Icon PLC  rose 0.01% to $168.93, and Quest Diagnostics Inc.  rose 0.20% to $245.00.Trading volume  remained 352,714 below its 50-day average volume of 881,416.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4559","DVA","BK4588","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662183917","title":"Press Release: Alebund Pharmaceuticals Announces 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662183917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662183917?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:48","pubTimestamp":1787741280,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals  Limited , a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 . During the Reporting Period and up to the date of the interim results announcement, the Company made significant progress on four fronts: clinical development, external collaborations, commercialization in China, and the capital markets.Highlights of the Reporting PeriodClinical Development-- AP301 -- patient enrollment completed in the global Phase III pivotal. multi-regional clinical trial; the New Drug Application in China accepted. for review by the National Medical Products Administration of China (the. \"NMPA\"). In May 2026, RESPOND-2, the global Phase III pivotal. and China, completed patient enrollment. On August 7, 2026, subsequent to. the Reporting Period, the New Drug Application submitted by the Company. for AP301 for the treatment of hyperphosphatemia in chron","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU2237443465.HKD","LU2237443895.HKD","BK4585","LU2237443978.SGD","BK4006","BK4022","R","LU1363072403.SGD","IE00BKVL7J92.USD","IE00BHPRN162.USD","LU2237443382.USD","DVA","LU0149725797.USD","LU2746668974.SGD","LU0267386448.USD","BK4588","LU2237443549.SGD","LU2237443622.USD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU2746668461.USD","IE00B1BXHZ80.USD","LU0170899867.USD","IE00BFXG1179.USD","CMC","LU0882574139.USD","BK4232","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735732","title":"DaVita Reaches Kidney Care Agreement With Humana","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735732","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:42","pubTimestamp":1787654530,"startTime":"0","endTime":"0","summary":"DaVita (DVA) said Tuesday it formed a partnership with Humana (HUM) to treat Medicare Advantage members with chronic kidney disease stages 3B to 5.The program began in July and expands an existing rel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","BK7500","BK4154","LU0208291251.USD","SG9999014005.SGD","SG9999014013.SGD","FXH","LU0390134368.USD","HUM","LU0238689110.USD","LU0070302665.USD","LU1983260115.SGD","BK4559","BK4566","LU0211331839.USD","LU0417517546.SGD","BK7093","LU0348723411.USD","BK4585","LU0256863811.USD","BK4533","LU0266013472.USD","BK4588","HUM.AU","SG9999014021.USD","DVA","LU0320765489.SGD","BK4196","LU0170899867.USD","IHF","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733513","title":"DaVita Partners with Humana on Value-Based Care Program for CKD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733513","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733513?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652131,"startTime":"0","endTime":"0","summary":"DaVita partners with Humana on value-based care program for CKD patientsDaVita entered a value-based care partnership with Humana for Medicare Advantage members with CKD stages 3B-5.Program launched J","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL3QHxyD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0208291251.USD","HUM","SG9999014021.USD","LU0266013472.USD","BK4533","LU0320765489.SGD","LU0390134368.USD","LU0170899867.USD","BK4559","FXH","LU0238689110.USD","LU0348723411.USD","BK4154","BK4585","DVA","SG9999014005.SGD","LU0256863811.USD","LU1093756325.SGD","LU0417517546.SGD","LU0070302665.USD","SG9999014013.SGD","LU1983260115.SGD","BK4588","LU1093756168.USD","IHF","BK4196","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662338387","title":"DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662338387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662338387?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:00","pubTimestamp":1787652006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA6FNDSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4196","BK4585","DVA","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209030","title":"DaVita Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209030?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:15","pubTimestamp":1787606100,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  advanced 1.54% to $176.50 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.26% to 53,417.16 and the S&P 500 Index  falling 0.28% to 7,652.86.The stock's rise snapped a three-day losing streak.DaVita Inc. closed 28.68% below its 52-week high of $247.49, which the company achieved on August 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as UnitedHealth Group Inc.  rose 2.22% to $398.76, Icon PLC  rose 0.73% to $173.48, and Quest Diagnostics Inc.  fell 0.21% to $243.87.Trading volume  eclipsed its 50-day average volume of 883,393.Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4585","BK4588","DVA","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661623724","title":"DaVita Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661623724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661623724?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:31","pubTimestamp":1787261460,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  slipped 1.15% to $175.24 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.This was the stock's second consecutive day of losses.DaVita Inc. closed 29.19% short of its 52-week high of $247.49, which the company achieved on August 3rd.The stock underperformed when compared to some of its competitors Thursday, as UnitedHealth Group Inc.  fell 0.97% to $384.85, Icon PLC  rose 1.03% to $174.27, and Quest Diagnostics Inc.  fell 0.19% to $241.30.Trading volume  remained 404,099 below its 50-day average volume of 887,325.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA","BK4585","BK4559","BK4588","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437385","title":"DaVita Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437385?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:16","pubTimestamp":1787001360,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  slipped 1.87% to $176.70 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.52% to 7,745.06 and Dow Jones Industrial Average  falling 0.51% to 53,459.78.DaVita Inc. closed 28.60% short of its 52-week high of $247.49, which the company achieved on August 3rd.The stock underperformed when compared to some of its competitors Monday, as UnitedHealth Group Inc.  fell 1.52% to $395.62, Icon PLC  rose 3.86% to $169.45, and Quest Diagnostics Inc.  rose 0.48% to $235.52.Trading volume  remained 398,745 below its 50-day average volume of 898,195.Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA","BK4585","BK4196","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659246231","title":"Alphabet Becomes Berkshire Hathaway's Third-Largest Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2659246231","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659246231?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:42","pubTimestamp":1786743761,"startTime":"0","endTime":"0","summary":"UPDATE 2-Alphabet becomes Berkshire Hathaway's third-largest investmentAug 14 (Reuters)-Berkshire HathawayBRKa.Nsaid on Friday it boosted the size of its investment in AlphabetGOOGL.Oby 83% in the sec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL6N44B13E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXN","PBJ","DHI","GOOX","AXP","NAIL","CQTM","FCOM","ILDR","LEN","OGIG","DAL","APLY","PICK","TRUC","AAPL","VT","ABFL","WNDR","SPTE","JETS","SKYY","TRUO","STZ","XLP","SAAPLmain","KR","ALLY","JGRO","VOX","GOU","GOOGL","XLK","KO","BAC","GOOY","EFIV","IYF","DVA","SLX","GOOP","FDFF","SPFE0main","TFNS","FNCL","XLF","NUE","UYG","COF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659198686","title":"DaVita Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2659198686","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659198686?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:17","pubTimestamp":1786655820,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  shed 1.28% to $179.17 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.65% to 7,798.99 and the Dow Jones Industrial Average  rising 0.13% to 53,839.99.DaVita Inc. closed 27.61% below its 52-week high of $247.49, which the company achieved on August 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as UnitedHealth Group Inc.  fell 1.61% to $399.06, Icon PLC  rose 0.19% to $167.48, and Quest Diagnostics Inc.  fell 0.73% to $236.04.Trading volume  remained 252,793 below its 50-day average volume of 908,177.Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","DVA","BK4559","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659118787","title":"Truist Financial Remains a Hold on DaVita (DVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659118787","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659118787?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:26","pubTimestamp":1786587972,"startTime":"0","endTime":"0","summary":"In a report released on August 11, David S Macdonald from Truist Financial maintained a Hold rating on DaVita, with a price target of $215.00. The ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-hold-on-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-hold-on-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","DVA","BK4559","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659790202","title":"NYSE Order Imbalance 128806.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2659790202","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659790202?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:50","pubTimestamp":1786564205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAQN2MEC9B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","DVA","BK4559","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946537","title":"DaVita Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946537","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946537?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:17","pubTimestamp":1786483020,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  shed 2.91% to $178.34 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.32% to 7,728.20 and Dow Jones Industrial Average  falling 0.34% to 53,791.85.This was the stock's second consecutive day of losses.DaVita Inc. closed 27.94% below its 52-week high of $247.49, which the company achieved on August 3rd.The stock underperformed when compared to some of its competitors Tuesday, as UnitedHealth Group Inc.  fell 1.60% to $402.19, Icon PLC  fell 0.28% to $165.58, and Quest Diagnostics Inc.  fell 0.05% to $237.50.Trading volume  eclipsed its 50-day average volume of 900,916.Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","DVA","BK4585","BK4588","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954159","title":"Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:50","pubTimestamp":1786438213,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hims-hers-health-hims-lifestance-health-group-lfst-and-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hims-hers-health-hims-lifestance-health-group-lfst-and-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","DVA","LFST","FMED","HEAL","HIMY","HIMS","HIYY","HMYY","BK4535","THNR","BK4585","BK4588","BK4559","GLAM","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629428","title":"DaVita Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629428?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:14","pubTimestamp":1786137240,"startTime":"0","endTime":"0","summary":"DJ DaVita Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  rose 1.72% to $183.77 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.62% to 7,757.64 and the Dow Jones Industrial Average  rising 0.28% to 54,036.93.The stock's rise snapped a four-day losing streak.DaVita Inc. closed 25.75% short of its 52-week high of $247.49, which the company reached on August 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as UnitedHealth Group Inc.  rose 0.77% to $407.08, Icon PLC  rose 2.07% to $164.51, and Quest Diagnostics Inc.  fell 0.06% to $238.35.Trading volume  eclipsed its 50-day average volume of 880,219.Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DVA","BK4559","BK4588","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657649992","title":"DaVita is Maintained at Hold by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2657649992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657649992?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:25","pubTimestamp":1786109100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DVA/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA","BK4196","BK4585","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657761043","title":"Truist Adjusts Price Target on DaVita to $215 From $250, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657761043","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657761043?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:14","pubTimestamp":1786101258,"startTime":"0","endTime":"0","summary":"DaVita (DVA) has an average rating of hold and mean price target of $224.17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","DVA","BK4559","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663699","title":"CytoSorbents Q2 Adjusted Loss Narrows on Cost Controls","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663699","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663699?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:49","pubTimestamp":1786049369,"startTime":"0","endTime":"0","summary":"CytoSorbents Q2 adjusted loss narrows on cost controlsOverviewU.S. blood purification firm's Q2 revenue was flat yr/yr at $9.6 mlnAdjusted net loss per share improved yr/yr, reflecting cost controls a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431JI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909593.SGD","QGEN","BK4585","BK4082","DVA","CTSO","LU2433249047.HKD","LU1923622614.USD","BK4559","BK4121","BK4588","BK4196","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.davita.com","stockEarnings":[{"period":"1week","weight":0.0395},{"period":"1month","weight":-0.2502},{"period":"3month","weight":-0.0704},{"period":"6month","weight":0.156},{"period":"1year","weight":0.3282},{"period":"ytd","weight":0.5904}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.002865},{"month":2,"riseRate":0.483871,"avgChangeRate":-0.007883},{"month":3,"riseRate":0.548387,"avgChangeRate":0.019696},{"month":4,"riseRate":0.645161,"avgChangeRate":0.025606},{"month":5,"riseRate":0.612903,"avgChangeRate":0.026568},{"month":6,"riseRate":0.612903,"avgChangeRate":0.048539},{"month":7,"riseRate":0.548387,"avgChangeRate":-0.005018},{"month":8,"riseRate":0.419355,"avgChangeRate":-0.013677},{"month":9,"riseRate":0.566667,"avgChangeRate":0.017103},{"month":10,"riseRate":0.5,"avgChangeRate":0.001552},{"month":11,"riseRate":0.612903,"avgChangeRate":0.050929},{"month":12,"riseRate":0.580645,"avgChangeRate":0.040515}],"exchange":"NYSE","name":"DaVita HealthCare Partners","nameEN":"DaVita HealthCare Partners"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DaVita HealthCare Partners(DVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DaVita HealthCare Partners(DVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DaVita HealthCare Partners,DVA,DaVita HealthCare Partners股票,DaVita HealthCare Partners股票老虎,DaVita HealthCare Partners股票老虎国际,DaVita HealthCare Partners行情,DaVita HealthCare Partners股票行情,DaVita HealthCare Partners股价,DaVita HealthCare Partners股市,DaVita HealthCare Partners股票价格,DaVita HealthCare Partners股票交易,DaVita HealthCare Partners股票购买,DaVita HealthCare Partners股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DaVita HealthCare Partners(DVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DaVita HealthCare Partners(DVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}